RISE Performance Improvement Activity 2026
Description
RISE Performance Improvement is a three-stage performance improvement activity by which evidence-based performance measures and quality improvement interventions / changes are used to help providers identify patient care areas for improvement and positively change their performance.
Current RISE registry users will be able to assess their current quality measure performance in their 2026 RISE dashboard, select measures in which they would like to improve performance, implement changes within their practice for 90 consecutive days to improve measure performance, and re-assess measure performance to see if and how their performance changed.
Registration is complimentary.
Target Audience
Rheumatologists and primary care providers; professionals interested or engaged in rheumatology research.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Assess their performance on quality measures and identify which measures need performance improvement
- Identify and implement change(s) in their practice to improve their quality measure performance
- Assess their quality measure performance after
implementing the change(s) and summarize the outcome that resulted from
implementing the change(s)
CE & MOC Information
In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider Number: 0003797
See the ACR's CE Mission Statement. For more information, download the AMA PRA Booklet.
Credit must be claimed by December 31, 2026, at 11:59 PM ET.
All participating healthcare professionals should claim only the credit commensurate with the extent of their participation in this activity.
Available Credit
- AMA PRA Category 1 Credit(s)™: 20.00
- ABIM MOC: 20.00
AMA Designation Statement
The American College of Rheumatology designates this enduring material for a maximum of 20.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.MOC Recognition Statement: American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
Faculty and Disclosures
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
In accordance
with the ACCME Standards for Integrity and Independence in Accredited
Continuing Education, ACR has implemented mechanisms prior to the planning and
implementation of this CME activity to identify and mitigate all relevant
financial relationships for all individuals in a position to control the
content of this CME activity.
Nature of Financial Relationships
All individuals that participate in this activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
1. Advisor or review panel member
2. Consultant
3. Employee
4. Officer or Board Member
5. Grant/research support
6. Speaker/honoraria includes speaker’s bureau, symposia, and expert
witness
7. Independent contractor
8. Executive role and/or ownership interest
9. Royalties and/or patent beneficiary
10. Intellectual property/patents
11. Stock options or bond holdings in a for-profit corporation or
self-directed pension plan
12. Private investigator
13. Expert witness
14. Equity interest
15. Other: specify details
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. RISE Performance Improvement 2026 Financial Relationship Disclosures
Acknowledgement Commercial Support
No commercial support was provided for this activity.
See industry engagement opportunities and benefits of supporting the ACR.
Educational Activity Policies
See ACR educational activity policies, including the online enduring activity refund policy.